These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4651996)

  • 21. Evidence suggesting a dissociation of DNA strand scissions and late-stage promotion of tumor cell phenotype.
    Gensler HL; Bowden GT
    Carcinogenesis; 1983 Dec; 4(12):1507-11. PubMed ID: 6652866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity and mechanism(s) of promoter inhibitors in multistage promotion.
    Slaga TJ; Fischer SM; Weeks CE; Nelson K; Mamrack M; Klein-Szanto AJ
    Carcinog Compr Surv; 1982; 7():19-34. PubMed ID: 7039828
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulation of arachidonic acid release and metabolism by tumor promoters.
    Fischer SM; Lo HH; Maldve RE
    Adv Exp Med Biol; 1997; 400A():433-8. PubMed ID: 9547587
    [No Abstract]   [Full Text] [Related]  

  • 24. Antitumor-promoting effects of gallotannins extracted from various sources in mouse skin in vivo.
    Gali HU; Perchellet EM; Gao XM; Bottari V; Perchellet JP
    Anticancer Res; 1993; 13(4):915-22. PubMed ID: 7688939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicodynamics of tumour promoters of mouse skin. II. Binding to protein kinase C of some new diterpene esters and induction of luminol-enhanced chemoluminescence in mouse peritoneal neutrophils.
    Hergenhahn M; Kloz U; Fellhauer M; Tremp GL; Hecker E
    J Cancer Res Clin Oncol; 1991; 117(5):385-95. PubMed ID: 1653779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disturbance by tumor promotors of epidermal growth control (chalone mechanism).
    Marks F; Grimm W; Krieg L
    Hoppe Seylers Z Physiol Chem; 1972 Dec; 353(12):1970-2. PubMed ID: 4346531
    [No Abstract]   [Full Text] [Related]  

  • 27. Phorbol-12-myristate-13-acetate effect on cyclic adenosine 3',5'-monophosphate levels in mouse skin and inhibition of phorbol-myristate-acetate-promoted tumorigenesis by theophylline.
    Belman S; Troll W
    Cancer Res; 1974 Dec; 34(12):3446-55. PubMed ID: 4371963
    [No Abstract]   [Full Text] [Related]  

  • 28. Ability of the non-phorbol ester-type tumor-promoter thapsigargin to mimic the stimulatory effects of 12-0-tetradecanoylphorbol-13-acetate on ornithine decarboxylase activity, hydroperoxide production, and macromolecule synthesis in mouse epidermis in vivo.
    Perchellet EM; Gali HU; Gao XM; Perchellet JP
    Int J Cancer; 1993 Dec; 55(6):1036-43. PubMed ID: 8253522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nature of the epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice.
    Argyris TS
    Cancer Res; 1983 Apr; 43(4):1768-73. PubMed ID: 6403228
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of tumor promoters on lipid peroxidation in mouse skin.
    Logani MK; Solanki V; Slaga TJ
    Carcinogenesis; 1982; 3(11):1303-6. PubMed ID: 7151249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse skin ornithine decarboxylase induction and tumor promotion by cyclohexane.
    Gupta KP; Mehrotra NK
    Cancer Lett; 1990 Jun; 51(3):227-33. PubMed ID: 2112424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of the phosphorylation of mouse epidermal histones by tumor-promoting agents.
    Raineri R; Simsiman RC; Boutwell RK
    Cancer Res; 1973 Jan; 33(1):134-9. PubMed ID: 4682317
    [No Abstract]   [Full Text] [Related]  

  • 33. Initiating activity of aromatic hydrocarbons in two-stage carcinogenesis.
    Van Duuren BL; Sivak A; Goldschmidt BM; Katz C; Melchionne S
    J Natl Cancer Inst; 1970 May; 44(5):1167-73. PubMed ID: 5514475
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin.
    Van Duuren BL; Sivak A; Katz C; Seidman I; Melchionne S
    Cancer Res; 1975 Mar; 35(3):502-5. PubMed ID: 1116119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.
    Slaga TJ; Fischer SM; Nelson K; Gleason GL
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3659-63. PubMed ID: 6774342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of inhalation of citral and geraniol on the output and composition of respiratory tract fluid.
    Boyd EM; Sheppard EP
    Arch Int Pharmacodyn Ther; 1970 Nov; 188(1):5-13. PubMed ID: 5485103
    [No Abstract]   [Full Text] [Related]  

  • 37. D-Limonene modulates inflammation, oxidative stress and Ras-ERK pathway to inhibit murine skin tumorigenesis.
    Chaudhary SC; Siddiqui MS; Athar M; Alam MS
    Hum Exp Toxicol; 2012 Aug; 31(8):798-811. PubMed ID: 22318307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The protein kinase C activator L-alpha-dioctanoylglycerol: a potent stage II mouse skin tumor promoter.
    Verma AK
    Cancer Res; 1988 Apr; 48(7):1736-9. PubMed ID: 3127039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host factors in the susceptibility of mice to tumour initiating and promoting agents.
    Slaga TJ
    IARC Sci Publ; 1983; (51):257-73. PubMed ID: 6365772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple phenolic antioxidant protocatechuic acid enhances tumor promotion and oxidative stress in female ICR mouse skin: dose-and timing-dependent enhancement and involvement of bioactivation by tyrosinase.
    Nakamura Y; Torikai K; Ohto Y; Murakami A; Tanaka T; Ohigashi H
    Carcinogenesis; 2000 Oct; 21(10):1899-907. PubMed ID: 11023549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.